Back |
home / stock / cgen / cgen message board
Subject | By | Source | When |
---|---|---|---|
danrocks: CGEN Stock is number 230 for the largest percentage gain out of 250 stocks. $CGEN CGEN is | danrocks | investorshangout | 11/25/2014 7:53:58 PM |
danrocks: CGEN Stock is number 154 for the largest percentage gain out of 250 stocks. $CGEN CGEN is | danrocks | investorshangout | 11/24/2014 6:25:35 PM |
clayton: CGEN 7.14 Compugen Ltd $CGEN added to my watch list. Right now with CGEN I am watching the | clayton | investorshangout | 11/21/2014 6:09:38 PM |
clayton: CGEN 6.69 Compugen Ltd $CGEN added to my watch list. Right now with CGEN I am watching the | clayton | investorshangout | 11/20/2014 6:48:45 PM |
Emylers: CGEN 6.45 Compugen Ltd $CGEN Hit a 52 week low of 6.38 Closing the day 10:45 at 6.45 -0.17 | Emylers | investorshangout | 11/14/2014 4:13:51 PM |
News, Short Squeeze, Breakout and More Instantly...
Compugen to Release Second Quarter 2024 Results on Tuesday, August 6, 2024 PR Newswire HOLON, Israel , July 23, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target ...
Compugen to Present at Upcoming Antibody Industrial Symposium PR Newswire HOLON, Israel , June 17, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, t...
Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig PR Newswire Phase 3 trial evaluating rilvegostomig as monotherapy and in combination with AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan in ...